IP Library › Granted Patent US 10,933,000
Granted Patent B2
US 10,933,000 · App. 16/468,342 · Granted Mar 2, 2021

Aluminum-free antiperspirant / deodorant compositions

Inventors: Peter Hilliard, Jr. (Far Hills, NJ); Sharon Kennedy (Randallstown, MD); Darrick Carlone (New Vernon, NJ); Cristina Bielli (Hillsborough, NJ); Richard Adams (South Orange, NJ)
Assignee: Colgate-Palmolive Company
A61K8/27A61K8/0229A61K8/042A61K8/345A61K8/361A61K8/8164A61K8/8182A61Q15/00A61K2800/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,933,000
App. No.
16/468,342
Granted
Mar 2, 2021
Kind
B2
Abstract

An aluminum-free antiperspirant/deodorant composition in the form of stick, cream, or flowable gel includes a carrier that includes a polyhydric alcohol or is a mixture of a polyhydric alcohol and water; a thickening agent including a C 14-22 fatty acid salt; and an antiperspirant active and optionally a film-forming polymer dispersed in the carrier. The antiperspirant active is primarily a zinc-based antiperspirant active.

Claims (26)

1. An antiperspirant/deodorant composition comprising:

a) a base composition comprising:

a. a carrier comprising a polyhydric alcohol or a mixture of a polyhydric alcohol and water, wherein the polyhydric alcohol comprises an organic compound containing 2 to 6 carbon atoms and 2 to 6 hydroxy groups;

b. a thickening agent comprising a C 14-22 fatty acid salt, wherein the C 14-22 fatty acid salt comprises at least one of an alkali metal, an alkaline earth metal, a transition metal, or an amine salt of C 14-22 fatty acid;

b) an antiperspirant active and a film-forming polymer dispersed in the base composition,

wherein the antiperspirant active consists essentially of a zinc-based antiperspirant active, and

wherein the antiperspirant/deodorant composition is essentially free of magnesium-based actives.

2. The antiperspirant/deodorant composition of claim 1 , wherein the zinc-based antiperspirant active comprises one or more of zinc oxide, zinc hydroxide, zinc hydroxide ions, and zinc ions.

3. The antiperspirant/deodorant composition of claim 1 , wherein the antiperspirant/deodorant composition is essentially free of aluminum-based antiperspirant actives.

4. The antiperspirant/deodorant composition of claim 1 , wherein the zinc-based antiperspirant active comprises zinc oxide present in an amount of from 0.5 to 10 weight %, based on the total amount of the antiperspirant/deodorant composition.

5. The antiperspirant/deodorant composition of claim 1 , wherein the film-forming polymer comprises at least one of a copolymer of maleic anhydride and methyl vinyl ether crosslinked with 1,9-decadiene, a mixture of polyester-10 and propylene glycol dibenzoate; a mixture of polyester-7 and neopentyl glycol diheptanoate; adipic acid/diglycol crosspolymer; trimethylpentanediol/adipic acid/glycerin crosspolymer; trimethylpentanediol/adipic acid copolymer; capryloyl glycerin/sebacic acid copolymer; and an acyl substituted polyvinylpyrrolidone having an average acyl chain length of 16 to 30 carbon atoms.

6. The antiperspirant/deodorant composition of claim 1 , wherein the film forming polymer comprises a Copolymer of maleic anhydride and methyl vinyl ether crosslinked with 1,9-decadiene, present in an amount of 0.1 to 5 weight %, based on the total weight of the antiperspirant/deodorant composition.

7. The antiperspirant/deodorant composition of claim 1 , wherein the C 14-22 fatty acid salt comprises at least one of myristic, palmitic, stearic, behenic, oleic, linoleic, and linolenic acid, and one or more of sodium, potassium, calcium, magnesium, diethylamine, triethyl amine as a counterion.

8. The antiperspirant/deodorant composition of claim 1 , wherein the C 14-22 fatty acid salt comprises a completely or a partially neutralized stearic acid.

9. The antiperspirant/deodorant composition of claim 1 , wherein the C 14-22 fatty acid salt is present in an amount of 0.5 to 8 weight %, based on the total weight of the antiperspirant/deodorant composition.

10. The antiperspirant/deodorant composition of claim 1 , wherein the polyhydric alcohol is propylene glycol.

11. The antiperspirant/deodorant composition of claim 1 , wherein the polyhydric alcohol is present in an amount of 65 to 95 weight %, based on the total weight of the antiperspirant/deodorant composition.

12. The antiperspirant/deodorant composition of claim 1 , wherein the antiperspirant/deodorant composition is in the form of stick, cream, or flowable gel.

13. A method of reducing apparent perspiration comprising applying the antiperspirant/deodorant composition of claim 1 to an axillary area of a person, wherein the antiperspirant/deodorant composition of claim 1 reduces apparent perspiration.

14. An antiperspirant/deodorant composition comprising:

a) a base composition comprising:

(i) a carrier consisting essentially of a polyhydric alcohol or a mixture of a polyhydric alcohol and water, wherein the polyhydric alcohol comprises an organic compound containing 2 to 6 carbon atoms and 2 to 6 hydroxy groups;

(ii) a thickening agent comprising a C 14-22 fatty acid salt, wherein the C 14-22 fatty acid salt comprises at least one of an alkali metal, an alkaline earth metal, a transition metal, or an amine salt of C 14-22 fatty acid;

b) an antiperspirant active consisting essentially of a zinc-based antiperspirant active dispersed in the base composition,

wherein the antiperspirant/deodorant composition is essentially free of aluminum-based antiperspirant actives and magnesium-based actives.

15. The antiperspirant/deodorant composition of claim 14 , wherein the antiperspirant/deodorant composition is essentially free of morpholine, pyridine, acetic acid, ethylene carbonate, propylene carbonate, N-methyl pyrrolidone, pyrrolidone, butyrolactone, dimethylsulfoxide, dimethyl formamide, 2-ethoxyethanol, caprolactam.

Continuity (2)
Provisional Application 62434214 · Dec 14, 2016
Related Publication 20190298625A1 · Oct 3, 2019
Cited By (3)
US 12,194,124 US 12,201,713 US 12,251,584